This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It can be associated with reduced quality of life and complications such as heart failure and stroke. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace. So, again, innovation is great.
However, there is a paucity of information regarding the impact of AF on HCM employing validated quality of life (QoL) surveys. years before PROM, with 66% of patients treated with a rhythm control strategy with antiarrhythmic drug and/or AF ablation. AF was diagnosed at 55 ± 10 years of age, median of 5.5
ABSTRACT Background Catheter ablation improves symptoms and quality of life in atrial fibrillation patients, but its effect on adverse cardiovascular outcomes and mortality remains uncertain. that ablation is superior in reducing adverse cardiovascular outcomes and mortality, respectively.
Abstract Introduction The prospective, nonrandomized, multicenter Q-FFICIENCY study demonstrated the safety and 12-month efficacy of paroxysmal atrial fibrillation (AF) ablation with the novel QDOT MICRO temperature-controlled, contact force-sensing, radiofrequency (RF) catheter. 86.9%) and 88.8% (95% CI, 84.0%–93.7%), 93.7%), respectively.
CSS, carotid sinus syndrome; CSM, carotid sinus massage; HR, heart rate; SF-36 QLQ, SF-36 quality-of-life questionnaire. Cardioneuroablation could be a reasonable alternative to pacemaker implantation in symptomatic carotid sinus syndrome. Results A total of 13 consecutive patients (84.6% male, mean age 63.812.3 years) were included.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany. Image courtesy: European Society of Cardiology.
ABSTRACT Introduction The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. Central Illustration. Image is courtesy of Biosense Webster, Inc., All rights reserved.
Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. That is how the strategy of rhythm control by catheter ablation was thought of as a possible better strategy, though technically more challenging, not uniformly effective and having significant risk of complications.
Scott Rankin Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures The Annals of Thoracic Surgery June 2018 A. Chris Malaisrie Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting The Journal of Thoracic and Cardiovascular Surgery June 2018 J.
Scott Rankin 1 Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures The Annals of Thoracic Surgery June 2018 A. Chris Malaisrie Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting The Journal of Thoracic and Cardiovascular Surgery June 2018 J.
It is also common in patients with a history of prior heart surgery or catheter ablation. Catheter ablation has been established in randomized trials to be superior to medical management in terms of safety, efficacy, and clinical outcomes including hospitalization and quality of life.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content